Skip to main content

Lazard Asset Management Llc

Source: SEC Form 13F · as of Mar 2026

Lazard Asset Management Llc holds 47 biotech & pharma companies tracked by BioSniper, totaling $299.4M in value as of Mar 2026 (SEC Form 13F).

Companies held

47

Total value held

$299.4M

BioSniper AIPage evidence connected

Prepared research question

What matters most for ARGENX SE (ARGX)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
ARGXARGENX SE133,347$97.4M
GILDGILEAD SCIENCES, INC.299,734$41.8M
INCYIncyte Corp.219,881$20.7M
ONCBeOne Medicines Ltd.62,917$18.7M
BMRNBIOMARIN PHARMACEUTICAL INC325,851$18.4M
EXELEXELIXIS, INC.372,600$16.0M
RDYDR REDDYS LABORATORIES LTD1,059,831$14.7M
REGNREGENERON PHARMACEUTICALS, INC.17,004$13.1M
JAZZJazz Pharmaceuticals plc42,723$8.1M
ACADACADIA PHARMACEUTICALS INC246,297$5.5M
ALNYALNYLAM PHARMACEUTICALS, INC.16,280$5.4M
ARQTArcutis Biotherapeutics, Inc.154,566$3.6M
MPLTMapLight Therapeutics, Inc.142,016$2.9M
RYTMRHYTHM PHARMACEUTICALS, INC.32,888$2.9M
TLXTelix Pharmaceuticals Limited289,917$2.8M
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)49,946$2.8M
PCVXVaxcyte, Inc.47,023$2.7M
IRONDisc Medicine, Inc.39,400$2.5M
AXSMAxsome Therapeutics, Inc.13,163$2.2M
IONSIONIS PHARMACEUTICALS INC25,410$1.9M
PTCTPTC THERAPEUTICS, INC.25,988$1.8M
ESPREsperion Therapeutics, Inc.580,705$1.6M
ABSIAbsci Corporation530,130$1.6M
RXRXRECURSION PHARMACEUTICALS, INC.400,762$1.2M
NTLAIntellia Therapeutics, Inc.93,620$1.2M
SLNOSOLENO THERAPEUTICS INC32,664$1.1M
ABCLAbCellera Biologics Inc.305,224$1.1M
KNSAKiniksa Pharmaceuticals International, plc21,432$1.0M
MRNAModerna, Inc.11,364$577K
BBIOBridgeBio Pharma, Inc.7,421$551K
SNYSanofi10,783$520K
TERNTerns Pharmaceuticals, Inc.7,173$378K
FOLDAMICUS THERAPEUTICS, INC.24,184$350K
ADPTAdaptive Biotechnologies Corp25,098$348K
ARWRARROWHEAD PHARMACEUTICALS, INC.4,567$286K
ADMAADMA BIOLOGICS, INC.29,757$268K
ZYMEZymeworks Inc.10,602$265K
ARDXARDELYX, INC.44,269$265K
DAWNDay One Biopharmaceuticals, Inc.9,364$201K
PLXProtalix BioTherapeutics, Inc.86,617$188K
SIGASIGA TECHNOLOGIES INC24,519$131K
KROSKeros Therapeutics, Inc.11,705$129K
PBYIPUMA BIOTECHNOLOGY, INC.17,970$115K
GERNGERON CORP64,879$97K
CYTKCYTOKINETICS INC1,369$90K
IVVDInvivyd, Inc.20,933$27K
CHRSCoherus Oncology, Inc.10,514$18K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.